Trial Profile
A phase I imaging study to investigate once-daily formulations of centanafadine
Status:
Planning
Phase of Trial:
Phase I
Latest Information Update: 12 Jan 2016
Price :
$35
*
At a glance
- Drugs Centanafadine (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Pharmacokinetics
- 12 Jan 2016 New trial record